| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:'Time is prognosis' in heart failure : time-to-treatment initiation as a modifiable risk factor
Avtorji:ID Abdin, Amr (Avtor)
ID Anker, Stefan D. (Avtor)
ID Butler, Javed (Avtor)
ID Kindermann, Ingrid (Avtor)
ID Lainščak, Mitja (Avtor)
ID Lund, Lars H. (Avtor)
ID Metra, Marco (Avtor)
ID Mullens, Wilfried (Avtor)
ID Rosano, Giuseppe M. (Avtor)
ID Slawik, Jonathan (Avtor), et al.
Datoteke:.pdf Abdin-2021-_Time_is_prognosis__in_heart_failur.pdf (5,64 MB)
MD5: BE1E4918C0524E903EE53CC24A6639C3
 
URL https://doi.org/10.1002/ehf2.13646
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:FNM - Fakulteta za naravoslovje in matematiko
Opis:In heart failure (HF), acute decompensation can occur quickly and unexpectedly because of worsening of chronic HF or to new-onset HF diagnosed for the first time ('de novo'). Patients presenting with acute HF (AHF) have a poor prognosis comparable with those with acute myocardial infarction, and any delay of treatment initiation is associated with worse outcomes. Recent HF guidelines and recommendations have highlighted the importance of a timely diagnosis and immediate treatment for patients presenting with AHF to decrease disease progression and improve prognosis. However, based on the available data, there is still uncertainty regarding the optimal 'time-to-treatment' effect in AHF. Furthermore, the immediate post-worsening HF period plays an important role in clinical outcomes in HF patients after hospitalization and is known as the 'vulnerable phase' characterized by high risk of readmission and early death. Early and intensive treatment for HF patients in the 'vulnerable phase' might be associated with lower rates of early readmission and mortality. Additionally, in the chronic stable HF outpatient, treatments are often delayed or not initiated when symptoms are stable, ignoring the risk for adverse outcomes such as sudden death. Consequently, there is a dire need to better identify HF patients during hospitalization and after discharge and treating them adequately to improve their prognosis. HF is an urgent clinical scenario along all its stages and disease conditions. Therefore, time plays a significant role throughout the entire patient's journey. Therapy should be optimized as soon as possible, because this is beneficial regardless of severity or duration of HF. Time lavished before treatment initiation is recognized as important modifiable risk factor in HF.
Ključne besede:heart failure, prognosis, treatment
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:10.08.2021
Datum sprejetja članka:19.09.2021
Datum objave:16.10.2021
Založnik:J. Wiley & Sons
Leto izida:2021
Št. strani:Str. 4444-4453
Številčenje:Letn. 8, Št. 6
PID:20.500.12556/DKUM-89688 Novo okno
UDK:616.1/.4
COBISS.SI-ID:98748675 Novo okno
DOI:10.1002/ehf2.13646 Novo okno
ISSN pri članku:2055-5822
Datum objave v DKUM:05.08.2024
Število ogledov:268
Število prenosov:13
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:ESC heart failure
Založnik:J. Wiley & Sons
ISSN:2055-5822
COBISS.SI-ID:523661593 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Številka projekta:322900939
Akronim:TTR 219

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-9292
Naslov:Breme kaheksije in sarkopenije pri bolnikih s kroničnimi boleznimi: epidemiologija, patofiziologija in izidi

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-9284
Naslov:Epidemiologija, patofiziologija in klinični pomen pomanjkanja železa pri kroničnih kardiopulmonalnih boleznih

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.
Začetek licenciranja:16.10.2021

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:srčno popuščanje, potek bolezni, zdravljenje


Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici